Viking stock slides 8% following Q4 report, pipeline update
Shares of Viking Therapeutics (VKTX) slid 8% post-market after the biotech company issued its Q4 earnings report and a pipeline update. Read more here.
D.C. biotech Vanda Pharmaceuticals acquires AnaptysBio’s drug for rare skin disorder
D.C.’s Vanda Pharmaceuticals Inc. has locked in a deal with a West Coast biotech to commercialize a drug for a rare skin ...
Hosted on MSN3d
Vanda and AnaptysBio link for generalised pustular psoriasis therapy
Vanda Pharmaceuticals and AnaptysBio have announced an exclusive worldwide licence agreement to develop and commercialise the ...
Vanda stock holds Buy rating, $18 target from H.C. Wainwright
H.C. Wainwright maintained a Buy rating on Vanda Pharmaceuticals (NASDAQ:VNDA) with a price target of $18.00, representing significant upside potential from the current price of $4.31. According to ...
Yahoo Finance15d
Vanda Pharmaceuticals Inc. (VNDA)
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) letter to FDA Commissioner highlights faulty gastroparesis NDA review. Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the U.S. Food ...
Reuters15d
Indian drugmaker Dr Reddy's shares slide after Q3 profit miss
"The drop in shares comes as market sees near-term concerns over the company's muted U.S. sales," said Sumit Gupta, analyst at Centrum Broking. Indian generic drugmakers are struggling with slower ...
BioWorld15d
US Claims Court rules Vanda’s trade secrets not so secret
A U.S. Federal Claims Court judge shot down Vanda Pharmaceuticals Inc.’s accusations that the FDA disclosed the company’s trade secrets to generic competitors, finding that the trade secrets weren’t ...
U.S. News & World Report15d
Vanda Pharmaceuticals Inc
With California wildfires triggering a massive rebuilding process that could take several years, investors are looking closer at lumber stocks.
ENDPOINTS NEWS16d
Van­da los­es con­sti­tu­tion­al fight over FDA's drug talks with com­peti­tors
The FDA dodged claims from Van­da Phar­ma­ceu­ti­cals that it al­leged­ly vi­o­lat­ed the US Con­sti­tu­tion by rec­om­mend­ing the same drug spec­i­fi­ca­tions for both Van ...
Pharmaceutical Technology20d
VHX-896 by Vanda Pharmaceuticals for Schizophrenia: Likelihood of Approval
VHX-896 is under clinical development by Vanda Pharmaceuticals and currently in Phase III for Schizophrenia. According to GlobalData, Phase III drugs for Schizophrenia have a 68% phase transition ...
Pharmaceutical Technology20d
Tradipitant by Vanda Pharmaceuticals for Motion Sickness: Likelihood of Approval
Tradipitant is under clinical development by Vanda Pharmaceuticals and currently in Phase III for Motion Sickness. According to GlobalData, Phase III drugs for Motion Sickness have a 100% phase ...
The Rakyat Post22d
Malaysia’s First Glass Water Slide Makes A Splash At i-City
Subscribe to our FREE Newsletter, or Telegram and WhatsApp channels for the latest stories and updates. Malaysia’s first glass water slide is ready to welcome visitors at i-City Shah Alam as part of ...